Angiotensin receptor neprilysin inhibitors (ARNi), beyond blocking angiotensin II signaling, augment natriuretic peptides by inhibiting their breakdown by neprilysin. The myocardial effects of ARNi ...

Here, we develop a toolkit for capturing EEA1-positive endosomes (termed Endo-IP) and TMEM192-positive lysosomes (termed Lyso-IP) in stem cell-derived induced neurons (iNeurons). We demonstrate its ...

Associations between acupuncture and uses of opioids and neuropsychiatric medication following chemotherapy-induced peripheral neuropathy among patients with breast cancer. Pool analysis of Part A ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary ...

the absence of laboratory findings suggestive of hereditary angioedema, and the temporal association with ACE inhibitor use, the clinical diagnosis of perindopril-induced angioedema was made. Over the ...

Twenty-year old Noah Davis-Logan is a former national medalist in track, college student, and dedicated advocate for hereditary angioedema, or HAE. Noah has been living with this rare condition ...

Nottingham Forest striker Taiwo Awoniyi is set to be brought out of an induced coma on Wednesday, according to The Guardian, after undergoing an “urgent” abdominal procedure following a ...

A Premier League player was placed into an induced coma after he had to undergo surgery on an abdominal injury that was deemed “urgent,” various outlets reported on Tuesday. Nottingham Forest ...

An induced coma is a temporary state of unconsciousness brought on by medication. It’s often used to protect the brain or other organs from further damage as the controlled shutdown of the body ...

Nottingham Forest striker Taiwo Awoniyi has reportedly been placed into an induced coma following “urgent” surgery for a serious abdominal injury suffered during a Premier League match over ...

has accepted for Priority Review the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary angioedema (HAE). In the trial ...